Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
21421 | 419 | 26.3 | 62% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
73 | 3 | MICROBIOLOGY//INFECTIOUS DISEASES//STAPHYLOCOCCUS AUREUS | 82747 |
575 | 2 | VANCOMYCIN//LINEZOLID//DAPTOMYCIN | 14274 |
21421 | 1 | STREPTOGRAMIN//QUINUPRISTIN DALFOPRISTIN//DALFOPRISTIN | 419 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | STREPTOGRAMIN | authKW | 494406 | 5% | 32% | 21 |
2 | QUINUPRISTIN DALFOPRISTIN | authKW | 489857 | 5% | 31% | 22 |
3 | DALFOPRISTIN | authKW | 295137 | 2% | 45% | 9 |
4 | QUINUPRISTIN | authKW | 295137 | 2% | 45% | 9 |
5 | PRISTINAMYCIN | authKW | 255045 | 3% | 25% | 14 |
6 | PRISTINAMYCINS | authKW | 194333 | 1% | 67% | 4 |
7 | UNITE ST HYLOCOQUES | address | 178537 | 2% | 35% | 7 |
8 | STREPTOMYCES PRISTINAESPIRALIS | authKW | 138072 | 1% | 32% | 6 |
9 | PRISTINAMYCINS II | authKW | 97166 | 0% | 67% | 2 |
10 | ANTI BACTERIAL AGENTS PHARMACOLOGY THERAPEUTIC USE | authKW | 72876 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Infectious Diseases | 6032 | 36% | 0% | 150 |
2 | Microbiology | 5677 | 48% | 0% | 203 |
3 | Pharmacology & Pharmacy | 2941 | 49% | 0% | 205 |
4 | Chemistry, Medicinal | 12 | 2% | 0% | 10 |
5 | Biophysics | 12 | 3% | 0% | 13 |
6 | Biochemistry & Molecular Biology | 11 | 9% | 0% | 39 |
7 | Chemistry, Organic | 9 | 4% | 0% | 16 |
8 | Chemistry, Multidisciplinary | 8 | 6% | 0% | 26 |
9 | Medicine, General & Internal | 6 | 4% | 0% | 15 |
10 | Immunology | 4 | 4% | 0% | 15 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UNITE ST HYLOCOQUES | 178537 | 2% | 35% | 7 |
2 | ANTI INFECT CLIN | 72876 | 0% | 100% | 1 |
3 | ANTI INFECT CLIN CENT | 72876 | 0% | 100% | 1 |
4 | BIOMOL BIOCHEM CHEM SCI MICROBIOL M502 | 72876 | 0% | 100% | 1 |
5 | BIOPROC AGRO ALIMENTAI | 72876 | 0% | 100% | 1 |
6 | COVANCE CLIN UNIT | 72876 | 0% | 100% | 1 |
7 | FRENCH REG REFERENCE BONE JOINT INFECT | 72876 | 0% | 100% | 1 |
8 | IMMUNOL INFECT DIS PNEUMOL 1 | 72876 | 0% | 100% | 1 |
9 | PHARMACEUT SCIPROD DEV | 72876 | 0% | 100% | 1 |
10 | RELAT HOTE MICROORGAN EPITHELIUMS | 72876 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 37470 | 19% | 1% | 80 |
2 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 10011 | 14% | 0% | 57 |
3 | BULLETIN DES SOCIETES CHIMIQUES BELGES | 5519 | 3% | 1% | 13 |
4 | DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 3489 | 4% | 0% | 16 |
5 | MICROBIAL DRUG RESISTANCE | 1002 | 1% | 0% | 4 |
6 | INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 923 | 2% | 0% | 7 |
7 | EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 730 | 2% | 0% | 8 |
8 | JOURNAL OF CHEMOTHERAPY | 728 | 1% | 0% | 5 |
9 | MEDECINE ET MALADIES INFECTIEUSES | 684 | 1% | 0% | 6 |
10 | DRUGS | 626 | 2% | 0% | 7 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LAMB, HM , FIGGITT, DP , FAULDS, D , (1999) QUINUPRISTIN/DALFOPRISTIN - A REVIEW OF ITS USE IN THE MANAGEMENT OF SERIOUS GRAM-POSITIVE INFECTIONS.DRUGS. VOL. 58. ISSUE 6. P. 1061 -1097 | 87 | 62% | 66 |
2 | DELGADO, G , NEUHAUSER, MM , BEARDEN, DT , DANZIGER, LH , (2000) QUINUPRISTIN-DALFOPRISTIN: AN OVERVIEW.PHARMACOTHERAPY. VOL. 20. ISSUE 12. P. 1469-1485 | 60 | 75% | 31 |
3 | BARRIERE, JC , BERTHAUD, N , BEYER, D , DUTKA-MALEN, S , PARIS, JM , DESNOTTES, JF , (1998) RECENT DEVELOPMENTS IN STREPTOGRAMIN RESEARCH.CURRENT PHARMACEUTICAL DESIGN. VOL. 4. ISSUE 2. P. 155 -180 | 73 | 57% | 45 |
4 | BONFIGLIO, G , FURNERI, PM , (2001) NOVEL STREPTOGRAMIN ANTIBIOTICS.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 10. ISSUE 2. P. 185 -198 | 44 | 60% | 13 |
5 | BEARDEN, DT , (2004) CLINICAL PHARMACOKINETICS OF QUINUPRISTIN/DALFOPRISTIN.CLINICAL PHARMACOKINETICS. VOL. 43. ISSUE 4. P. 239-252 | 31 | 78% | 11 |
6 | BRYSON, HM , SPENCER, CM , (1996) QUINUPRISTIN-DALFOPRISTIN.DRUGS. VOL. 52. ISSUE 3. P. 406-415 | 33 | 85% | 33 |
7 | BOUANCHAUD, DH , (1997) IN-VITRO AND IN-VIVO ANTIBACTERIAL ACTIVITY OF QUINUPRISTIN/DALFOPRISTIN.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. VOL. 39. ISSUE . P. 15-21 | 27 | 93% | 46 |
8 | GRISWOLD, MW , LOMAESTRO, BM , BRICELAND, LL , (1996) QUINUPRISTIN-DALFOPRISTIN (RP 59500): AN INJECTABLE STREPTOGRAMIN COMBINATION.AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. VOL. 53. ISSUE 17. P. 2045-2053 | 36 | 75% | 20 |
9 | LOMAESTRO, BM , BRICELAND, LL , (1998) STREPTOGRAMINS AND THEIR POTENTIAL ROLE IN GERIATRIC MEDICINE.DRUGS & AGING. VOL. 13. ISSUE 6. P. 443 -465 | 40 | 60% | 1 |
10 | LOW, DE , (1995) QUINUPRISTIN/DALFOPRISTIN: SPECTRUM OF ACTIVITY, PHARMACOKINETICS, AND INITIAL CLINICAL EXPERIENCE.MICROBIAL DRUG RESISTANCE. VOL. 1. ISSUE 3. P. 223-234 | 29 | 81% | 56 |
Classes with closest relation at Level 1 |